Miranda Magdalena, Morici Juan Facundo, Zanoni María Belén, Bekinschtein Pedro
Laboratory of Memory Research and Molecular Cognition, Institute for Cognitive and Translational Neuroscience, Instituto de Neurología Cognitiva, CONICET, Universidad Favaloro, Buenos Aires, Argentina.
Front Cell Neurosci. 2019 Aug 7;13:363. doi: 10.3389/fncel.2019.00363. eCollection 2019.
Brain Derived Neurotrophic Factor (BDNF) is a key molecule involved in plastic changes related to learning and memory. The expression of BDNF is highly regulated, and can lead to great variability in BDNF levels in healthy subjects. Changes in BDNF expression are associated with both normal and pathological aging and also psychiatric disease, in particular in structures important for memory processes such as the hippocampus and parahippocampal areas. Some interventions like exercise or antidepressant administration enhance the expression of BDNF in normal and pathological conditions. In this review, we will describe studies from rodents and humans to bring together research on how BDNF expression is regulated, how this expression changes in the pathological brain and also exciting work on how interventions known to enhance this neurotrophin could have clinical relevance. We propose that, although BDNF may not be a valid biomarker for neurodegenerative/neuropsychiatric diseases because of its disregulation common to many pathological conditions, it could be thought of as a marker that specifically relates to the occurrence and/or progression of the mnemonic symptoms that are common to many pathological conditions.
脑源性神经营养因子(BDNF)是一种与学习和记忆相关的可塑性变化有关的关键分子。BDNF的表达受到高度调控,并且在健康受试者中会导致BDNF水平的巨大差异。BDNF表达的变化与正常衰老和病理性衰老以及精神疾病都有关,特别是在对记忆过程重要的结构中,如海马体和海马旁区域。一些干预措施,如运动或给予抗抑郁药,在正常和病理条件下都会增强BDNF的表达。在这篇综述中,我们将描述来自啮齿动物和人类的研究,以汇总关于BDNF表达如何被调控、这种表达在病理性大脑中如何变化以及关于已知增强这种神经营养因子的干预措施如何具有临床相关性的激动人心的研究。我们提出,尽管由于BDNF在许多病理条件下的失调,它可能不是神经退行性/神经精神疾病的有效生物标志物,但它可以被认为是一种与许多病理条件共有的记忆症状的发生和/或进展特别相关的标志物。